Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice.
about
Specific in vivo knockdown of protein function by intrabodiesNucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.Epimedium koreanum Nakai displays broad spectrum of antiviral activity in vitro and in vivo by inducing cellular antiviral state.Inhibitory effects of an aqueous extract from Cortex Phellodendri on the growth and replication of broad-spectrum of viruses in vitro and in vivo.Synthetic Human TLR9-LRR11 Peptide Attenuates TLR9 Signaling by Binding to and thus Decreasing Internalization of CpG Oligodeoxynucleotides.Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9.Toll-like receptors and lupus nephritis.Essential role of high-mobility group box proteins in nucleic acid-mediated innate immune responses.Modulating toll-like receptor 7 and 9 responses as therapy for allergy and autoimmunity.New approaches for the treatment of lupus nephritis in the 21st century: from the laboratory to the clinic.Interferon-mediated antiviral activities of Angelica tenuissima Nakai and its active components.Molecular cloning and characterization of a novel anti-TLR9 intrabody.A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW/F1 mice.Dense Granule Protein-7 (GRA-7) of Toxoplasma gondii inhibits viral replication in vitro and in vivo.Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice.
P2860
Q26801077-BA2C66FA-C8BA-43D2-B8F1-AAD759532386Q34017633-334F72E9-73E1-4FEE-9C96-C49F98129978Q35014961-86809A0A-69C5-4BFA-AF61-2C3D8377A6DBQ36092992-C993F9CD-5AFC-410E-BD3D-2D1E74699378Q36667176-4531BBA8-3955-4626-8DB6-A6A3E9524757Q37758263-87CF7DD4-927B-42A2-888E-0AB4F803D212Q37769432-4850C07D-CDF5-44C5-AA20-B438B0A02208Q37906759-72004EA8-0CBF-448B-9F63-B2DAF8643E8DQ37956536-D015417F-E00D-4826-A642-877B8B7E16F8Q38148585-D350CCA4-721B-467A-BD5B-87E08F637343Q38806784-AAD84E3E-723C-4E7E-89E6-B1C4CC67A3A7Q39119214-FC903CAC-D11E-4FAE-AD90-6CFA44C60199Q44175614-F78867CB-F0F0-4754-B912-063720FF8742Q47596868-89C6A369-F040-4DAD-AEC2-CA650ED39758Q51516999-54BA5400-9FAE-46B3-8DB9-6009B3DFD01F
P2860
Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Treatment with a toll-like rec ...... lupus nephritis in NZB/W mice.
@ast
Treatment with a toll-like rec ...... lupus nephritis in NZB/W mice.
@en
Treatment with a toll-like rec ...... lupus nephritis in NZB/W mice.
@nl
type
label
Treatment with a toll-like rec ...... lupus nephritis in NZB/W mice.
@ast
Treatment with a toll-like rec ...... lupus nephritis in NZB/W mice.
@en
Treatment with a toll-like rec ...... lupus nephritis in NZB/W mice.
@nl
prefLabel
Treatment with a toll-like rec ...... lupus nephritis in NZB/W mice.
@ast
Treatment with a toll-like rec ...... lupus nephritis in NZB/W mice.
@en
Treatment with a toll-like rec ...... lupus nephritis in NZB/W mice.
@nl
P2093
P2860
P1433
P1476
Treatment with a toll-like rec ...... lupus nephritis in NZB/W mice.
@en
P2093
John P Higgins
Kareem L Graham
Lawrence Steinman
Lowen Y Lee
Paul J Utz
Peggy P Ho
P2860
P304
P356
10.3109/08916930903229239
P577
2010-03-01T00:00:00Z